Applications of machine learning in computer-aided drug discovery
QRB Discovery · 2022 · 3
DOI: 10.1017/qrd.2022.12 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift QRB Discovery, online erschienen am 01.09.2022. Verfasst von Sm Bargeen Alam Turzo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Machine learning (ML) has revolutionised the field of structure-based drug design (SBDD) in recent years. During the training stage, ML techniques typically analyse large amounts of experimentally determined data to create predictive models in order to inform the drug discovery process. Deep learning (DL) is a subfield of ML, that relies on multiple layers of a neural network to extract significantly more complex patterns from experimental data, and has recently become a popular choice in SBDD. This review provides a thorough summary of the recent DL trends in SBDD with a particular focus on de novo drug design, binding site prediction, and binding affinity prediction of small molecules.
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Sm Bargeen Alam Turzo, Eric R Hantz, Steffen Lindert
Zitieren
APA
Turzo, S. B. A., Hantz, E. R., & Lindert, S. (2022). Applications of machine learning in computer-aided drug discovery. QRB Discovery, 3. https://doi.org/10.1017/qrd.2022.12
Vancouver
Turzo SBA, Hantz ER, Lindert S. Applications of machine learning in computer-aided drug discovery. QRB Discovery. 2022;3. doi:10.1017/qrd.2022.12
BibTeX
@article{Turzo2022,
author = {Turzo, Sm Bargeen Alam and Hantz, Eric R and Lindert, Steffen},
title = {Applications of machine learning in computer-aided drug discovery},
journal = {QRB Discovery},
year = {2022},
volume = {3},
doi = {10.1017/qrd.2022.12}
}
EUVIMED